Jin Tong

628 total citations
11 papers, 471 citations indexed

About

Jin Tong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jin Tong has authored 11 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Jin Tong's work include Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Jin Tong is often cited by papers focused on Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Jin Tong collaborates with scholars based in China and United States. Jin Tong's co-authors include Zhi Hua Ran, Jun Shen, Shengen Xiao, Qiang Fu, Weijie Chen, Zengzhang Liu, Qiang Fu, Qian Shen, Xing Li and Wenhuan Bu and has published in prestigious journals such as Medicine, Alimentary Pharmacology & Therapeutics and Experimental Biology and Medicine.

In The Last Decade

Jin Tong

11 papers receiving 456 citations

Peers

Jin Tong

SURGE

MB

GASTR

CR

PRM

Rosa Rosania Italy

Yuta Fuyuno Japan

Ji Hyun Lim South Korea

Nic P. Mapstone United Kingdom

Pao‐Yuan Huang Taiwan

Tamaki Ikuse Japan

Young‐Jae Hwang South Korea

Tzu‐Chan Hong Taiwan

Shigeki Koyama Japan

Rosa Rosania Italy

Jin Tong

176 ×0.7

SURGE

63 ×0.4

MB

132 ×0.8

GASTR

21 ×0.2

CR

79 ×0.9

PRM

Citations per year, relative to Jin Tong Jin Tong (= 1×) peers Rosa Rosania

Countries citing papers authored by Jin Tong

Since Specialization

Citations

This map shows the geographic impact of Jin Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Tong more than expected).

Fields of papers citing papers by Jin Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Tong. The network helps show where Jin Tong may publish in the future.

Co-authorship network of co-authors of Jin Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Tong. A scholar is included among the top collaborators of Jin Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Tong. Jin Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Mao, Jie, Xiaoli Zhang, Ping Wang, et al.. (2023). CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer. Digestive and Liver Disease. 56(2). 330–342. 32 indexed citations

2.

Shen, Qian, Gang Zheng, Jin Tong, et al.. (2021). CircRNA circ_0092314 Induces Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells via Elevating the Expression of S100P by Sponging miR-671. Frontiers in Oncology. 11. 675442–675442. 26 indexed citations

3.

Xu, Huiting, Runzhi Chen, Qian Shen, et al.. (2021). Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway. Frontiers in Oncology. 11. 754146–754146. 21 indexed citations

4.

Tong, Jin, et al.. (2020). Long non‑coding RNA LINC00858 promotes TP53‑wild‑type colorectal cancer progression by regulating the microRNA‑25‑3p/SMAD7 axis. Oncology Reports. 43(4). 1267–1277. 12 indexed citations

5.

Bu, Wenhuan, Xing Li, Lili Liu, et al.. (2020). Long non-coding RNA TIRY promotes tumor metastasis by enhancing epithelial-to-mesenchymal transition in oral cancer. Experimental Biology and Medicine. 245(7). 585–596. 37 indexed citations

6.

Zhang, Jing, et al.. (2020). OTU deubiquitinase 5 inhibits the progression of non‐small cell lung cancer via regulating p53 and PDCD5. Chemical Biology & Drug Design. 96(2). 790–800. 15 indexed citations

7.

Tong, Jin, et al.. (2018). Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel. Medicine. 97(3). e9638–e9638. 37 indexed citations

8.

Tong, Jin, Xin Liu, Ronaldo G. Maghirang, et al.. (2017). Investigation of the potential and mechanism of clove for mitigating airborne particulate matter emission from stationary sources. Journal of Bionic Engineering. 14(2). 390–400. 5 indexed citations

9.

Tong, Jin, Zhi Hua Ran, Jun Shen, & Shengen Xiao. (2008). Sequential therapy vs. standard triple therapies forHelicobacter pyloriinfection: a meta-analysis. Journal of Clinical Pharmacy and Therapeutics. 34(1). 41–53. 89 indexed citations

10.

Tong, Jin, et al.. (2006). Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Alimentary Pharmacology & Therapeutics. 25(2). 155–168. 196 indexed citations

11.

Yang, Xiaofeng, et al.. (1996). Clnical and experimental study on composite Wuzi Dihuang Liquor in treating male infertility. Chinese Journal of Integrative Medicine. 2(1). 5–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact